1-15 of 15
Atto Billio
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Real-World Experience of CPX-351 in Combined French-Italian Cohorts Identified High Rate of Negative Measurable Residual Disease (MRD) and Prolonged Overall Survival

Thomas Cluzeau, Fabio Guolo, Edmond Chiche, Paola Minetto, Ramy Rahmé, Sarah Bertoli, Livio Pagano, Jean-Baptiste Micol, Michele Gottardi, Pierre Peterlin, Sara Galimberti, Xavier Thomas, Giuliana Rizzuto, Mohamad Mohty, Michela Rondoni, Emmanuel Raffoux, Giambattista Bertani, Alexis Caulier, Michelina Dargenio, Caroline Bonmati, Atto Billio, Caroline Lejeune, Barbara Scappini, Arnaud Pigneux, Patrizia Zappasodi, Christian Recher, Norbert Vey, Francesco Grimaldi, Lionel Ades, Roberto Massimo Lemoli
Journal: Blood
Blood (2023) 142 (Supplement 1): 4255.
https://doi.org/10.1182/blood-2023-177951
Published: 2023
Journal Articles

CPX-351 Induction in Secondary Acute Myeloblastic Leukemia: Extended Follow up from the Italian Compassionate Use Program

Paola Minetto, Fabio Guolo, Luana Fianchi, Marino Clavio, Michele Gottardi, Mauro Endri, Sara Galimberti, Giuliana Rizzuto, Margherita Sciumé, Michela Rondoni, Giambattista Bertani, Michelina Dargenio, Atto Billio, Barbara Scappini, Patrizia Zappasodi, Anna Maria Scattolin, Francesco Grimaldi, Giuseppe Pietrantuono, Pellegrino Musto, Cerrano Marco, Stefano D'Ardia, Ernesta Audisio, Alessandro Cignetti, Crescenza Pasciolla, Francesca Pavesi, Anna Candoni, Carmela Gurrieri, Monica Morselli, Caterina Alati, Nicola S Fracchiolla, Giovanni Rossi, Manuela Caizzi, Fabrizio Carnevale Schianca, Michele Cea, Agostino Tafuri, Giuseppe Rossi, Felicetto Ferrara, Livio Pagano, Roberto Massimo Lemoli
Journal: Blood
Blood (2021) 138 (Supplement 1): 1262.
https://doi.org/10.1182/blood-2021-153028
Published: 2021
Journal Articles

Combined Elevated Anti-Adamts-13 Antibody Level and Low Adamts-13 Activity during Remission Highly Predicts Disease Relapse in a Prospective Cohort of Patients with Autoimmune Thrombotic Thrombocytopenic Purpura (TTP)

Francesca Schieppati, MD, Laura Russo, Marina Marchetti, Gloria Caldara, Shenaz Brevi, Maria Testa, Luca Barcella, Monica Carpenedo, Mariella D'Adda, Giuseppe Rossi, Chiara Savignano, Atto Billio, Massimiliano Bruno Franco, Vincenzo Toschi, Anna Falanga
Journal: Blood
Blood (2018) 132 (Supplement 1): 2443.
https://doi.org/10.1182/blood-2018-99-119317
Published: 2018
Journal Articles

Efficacy and Safety of Bendamustine and Rituximab As First Salvage Treatment in Chronic Lymphocytic Leukemia: Results of the Gimema-Eric LLC1315 Study

Antonio Cuneo, MD, Gian Matteo Rigolin, Alfonso Piciocchi, Carol Moreno, MD, Atto Billio, Agostino Cortelezzi, Prof, Piero Galieni, MD, Luca Laurenti, Francesca Romana Mauro, Stefano Molica, MD, Massimo Gentile, MD, Marco Montillo, MD, Livio Trentin, MD, Angeles Medina Perez, Marta Coscia, Gerardo Musuraca, MD, Lucia Farina, Alfredo Rivas-Delgado, MD, Ester Maria Orlandi, MD, Stefania Ciolli, MD, Carlo Visco, Michele Pizzuti, MD, Roberto Marasca, Monia Marchetti, MD, Francesca Re, Marcos González, MD, Annalisa Chiarenza, MD PhD, Vittorio Meneghini, Fiorella Ilariucci, Gianluca Gaidano, MD PhD, Marco Vignetti, Javier De la Serna, MD, Robin Foa, MD, George A Follows, MD PhD, Paolo Ghia
Journal: Blood
Blood (2017) 130 (Supplement 1): 4330.
https://doi.org/10.1182/blood.V130.Suppl_1.4330.4330
Published: 2017
Journal Articles

Prolonged Survival Of Poor Risk Follicular Lymphoma Patients Following Primary Treatment With Rituximab-Supplemented CHOP Or HDS With Autograft: Long-Term Results Of The Multicenter Randomized GITMO/FIL Trial

Corrado Tarella, MD, Fabio Benedetti, MD, Carola Boccomini, MD, Caterina Patti, MD, Anna Maria Barbui, MD, Alessandro Pulsoni, MD, Maurizio Musso, Anna Marina Liberati, Guido Gini, MD, Claudia Castellino, Fausto Rossini, Fabio Ciceri, M.D., Delia Rota Scalabrini, MD, Caterina Stelitano, Francesco Di Raimondo, MD, Tommasina Perrone, Alessandra Tucci, Atto Billio, MD, Francesco Zallio, MD, Valerio Zoli, MD, Angela Congiu, Franco Narni, MD, Alessandra Dondi, Guido Parvis, MD, Gianpietro Semenzato, MD, Paolo Corradini, Riccardo Bruna, MD, Angela Gueli, MD, Barbara Mantoan, Roberto Passera, Michele Magni, MD, Marco Ladetto
Journal: Blood
Blood (2013) 122 (21): 551.
https://doi.org/10.1182/blood.V122.21.551.551
Published: 2013
Journal Articles

Chemoimmunotherapy with R-CHOP or High Dose Sequential Therapy with Autologous Stem Cell Transplantation (R-HDS) for High Risk Diffuse Large B-Cell Lymphomas Patients: Results of the Randomized R-HDS0305 Trial by Gruppo Italiano Terapie Innovative Nei Linfomi (GITIL)

Sergio Cortelazzo, MD, Corrado Tarella, MD, Alessandro Massimo Gianni, MD, Tiziano Barbui, MD, Marco Ladetto, MD, Anna Maria Barbui, MD, Andrea Rossi, MD, Paolo Corradini, MD, Massimo Di Nicola, MD, Caterina Patti, MD, Antonino Mulé, MD, Manuela Zanni, MD, Valerio Zoli, MD, Atto Billio, MD, Andrea Gallamini, MD, Francesco Di Raimondo, MD, Andrés J.M. Ferreri, MD, Giovanni Pizzolo, MD, Giorgio La Nasa, MD, Pietro Leoni, MD, Giampietro Semenzato, MD, Maurizio Frezzato, MD, Leonardo Flenghi, MD, Marco Scarano, Sc.D., Arianna Masciulli, BSc, Roberto Marchioli, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2012) 120 (21): 746.
https://doi.org/10.1182/blood.V120.21.746.746
Published: 2012
Journal Articles

High Response Rate with Favorable Survival Projections in High-Risk Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Receiving R-CHOP-14 or Early Intensified Chemotherapy with Rituximab and Autograft (R-HDS): Results of the Interim Analysis of A GITIL Prospective Multicenter Phase III Study.

Sergio Cortelazzo, MD, Corrado Tarella, MD, Alessandro M. Gianni, MD, Marco Ladetto, MD, Manuela Zanni, MD, Paolo Corradini, MD, Massimo Di Nicola, MD, Caterina Patti, MD, Antonino Mulè, MD, Ignazio Majolino, MD, Atto Billio, MD, Angela Gueli, MD, Francesco Di Raimondo, MD, Annalisa Chiarenza, MD, Andrea Gallamini, MD, Andres Ferreri, MD, Giovanni Pizzolo, MD, Fabio Benedetti, MD, Giorgio La Nasa, MD, Pietro Leoni, MD, Guido Gini, MD, Livio Trentin, MD, Francesco Rodeghiero, MD, Roberto Marchioli, MD, Tiziano Barbui, MD, Anna Barbui, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2009) 114 (22): 1220.
https://doi.org/10.1182/blood.V114.22.1220.1220
Published: 2009
Journal Articles

Safety and Efficacy of Bendamustine with or without Rituximab for the Treatment of Heavily Pretreated CLL and Lymphoma Patients. A Multicenter Retrospective Study.

Luigi Rigacci, Benedetta Puccini, Enrico Orciuolo, Alfonso D'Arco, Sergio Storti, Gianluca Gaidano, Roberto Freilone, Nicola Di Renzo, MD, Caterina Patti, MD, Alessandro Isidori, MD, PhD, Pier Luigi Zinzani, MD, Marco Gobbi, MD, Pellegrino Musto, MD, Anna Marina Liberati, MD, Andrea Carpaneto, Sergio Cortelazzo, Nicola Cascavilla, MD, Nadia Cecconi, Valeria Belsito Petrizzi, Giulio Giordano, MD, Silvia Franceschetti, Atto Billio, Alberto Bosi, MD
Journal: Blood
Blood (2009) 114 (22): 1662.
https://doi.org/10.1182/blood.V114.22.1662.1662
Published: 2009
Journal Articles

A GITIL Prospective Randomized Multicenter Phase III Study of High Dose Sequential Chemotherapy with Rituximab (R-HDS) and Autologous Transplantation (ASCT) of Peripheral Blood Stem Cells Versus CHOP and Rituximab Delivered Every 14 Days (R-CHOP-14) in High-Risk Patients with Diffuse Large B-Cell Lymphomas (DLBCL): Interim Analysis on Feasibility and Toxicity (Protocol R-HDS 0305).

Sergio Cortelazzo, MD, Atto Billio, MD, Alessandro Rambaldi, MD, Corrado Tarella, MD, Ingnazio Majolino, MD, Alessandro M. Gianni, MD, Paolo Corradini, MD, Catterina Patti, MD, Salvo Mirto, MD, Giovanna Borrelli, PhD, Roberto Marchioli9, MD
Journal: Blood
Blood (2007) 110 (11): 1898.
https://doi.org/10.1182/blood.V110.11.1898.1898
Published: 2007
Journal Articles

High-Dose Sequential Chemotherapy (HDS) Followed by Autologous Stem Cell Transplantation (ASCT) in Relapsing/Refractory Hodgkin Lymphoma (HL): Long-Term Results.

Andrea Gallamini, Claudia Castellino, Simonetta Viviani, Andrea Rossi, Atto Billio, Alessandro Mistretta, Marco Sorio, Angela Gueli, Alessandro Rambaldi, Sergio Cortelazzo, Caterina Patti, Fabio Benedetti, PierFederico Torchio, Alessandro M. Gianni, Corrado Tarella
Journal: Blood
Blood (2007) 110 (11): 5118.
https://doi.org/10.1182/blood.V110.11.5118.5118
Published: 2007
Journal Articles

Expression of the Human Concentrative Nucleotide Transporter (hCNT1) Gene Correlates with Clinical Response in Patients Affected by Waldenstrom’s Macroglobulinemia (WM), Undergoing a Combination Treatment with Cladribine (2-CdA) and Rituximab.

Daniele Laszlo, MD, Cristina Rabascio, DSc, Giovanna Andreola, MD, Luca Saronni, DSc, Liliana Calabrese, DSc, Luigi Rigacci, MD, Alberto Fabbri, MD, Antonello Pinto, MD, Ferdinando Frigeri, MD, Atto Billio, MD, Graziella Pinotti, MD, Simona Sammassimo, MD, Giovanni Martinelli, MD
Journal: Blood
Blood (2007) 110 (11): 1357.
https://doi.org/10.1182/blood.V110.11.1357.1357
Published: 2007
Journal Articles

Update of a GITIL Cohort Study: Frontline High Dose Sequential Chemotherapy with Rituximab and Autologous Stem Cell Transplantation Induces a High Rate of Long-Term Remissions in Patients with Mantle Cell Lymphoma

Sergio Cortelazzo, MD, Michele Magni, MD, Corrado Tarella, MD, Michael Mian, MD, Atto Billio, MD, Andrea Rossi, MD, Maddalena Marchesi, MD, Andrea Gallamini, MD, Paolo Corradini, MD, Fabio Ciceri, MD, Guido Parvis, MD, Ignazio Majolino, MD, Caterina Patti, MD, Salvo Mirto, MD, Fabio Benedetti, MD, Giovanni Pizzolo, MD, Alessandro M. Gianni, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2007) 110 (11): 1282.
https://doi.org/10.1182/blood.V110.11.1282.1282
Published: 2007
Journal Articles

Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial

Clinical Trials & Observations
Andrea Gallamini, Francesco Zaja, Caterina Patti, Atto Billio, Maria Rosaria Specchia, Alessandra Tucci, Alessandro Levis, Annunziata Manna, Vicenzo Secondo, Luigi Rigacci, Antonello Pinto, Emilio Iannitto, Valerio Zoli, Pierfederico Torchio, Stefano Pileri, Corrado Tarella
Journal: Blood
Blood (2007) 110 (7): 2316–2323.
https://doi.org/10.1182/blood-2007-02-074641
Published: 2007
Journal Articles

Frontline High Dose Sequential Chemotherapy with Rituximab (R-HDS) and Autologous Stem Cell Transplantation Induces High Rates of Complete Response and Prolongs Survival in Mantle Cell Lymphoma (MCL).

Sergio Cortelazzo, MD, Michele Magni, MD, Milena Pintimalli, MD, Michael Mian, MD, Andrea Rossi, MD, Atto Billio, MD, Maddalena Marchesi, MD, Manuela Zanni, MD, Corrado Tarella, MD, Mario Boccadoro, MD, Angelo Andreini, MD, Fabio Benedetti, MD, Giovanni Pizzolo, MD, Tiziano Barbui, MD, Alessandro M. Gianni, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2006) 108 (11): 3045.
https://doi.org/10.1182/blood.V108.11.3045.3045
Published: 2006
Journal Articles

Favorable Influence of Rituximab with High Dose Sequential Chemotherapy (R-HDS) Programs and Autologous Stem Cell Transplantation (ASCT) in Salvage Treatment for Patients with Refractory or Relapsed B-Cell Non-Hodgkin’s Lymphoma.

Milena Pintimalli, MD, Michael Mian, MD, Andrea Rossi, MD, Marco Sorio, MD, Fabio Benedetti, MD, Giovanni Pizzolo, MD, Atto Billio, MD, Tiziano Barbui, MD, Alessandro Rambaldi, MD, Sergio Cortelazzo, MD
Journal: Blood
Blood (2006) 108 (11): 2744.
https://doi.org/10.1182/blood.V108.11.2744.2744
Published: 2006